Clinical Trials | December 21, 2025
Soligenix publishes promising Phase 2a data for SGX945 in Behcet's Disease
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
The update promises to revolutionize laboratory workflows by optimizing resources
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The state-of-the-art facility is expected to be commissioned over the next three years
India plays a critical role in Bristol Myers Squibb’s global strategy
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
All pending litigation between Biocon Biologics, Regeneron, and Bayer will be dismissed
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Subscribe To Our Newsletter & Stay Updated
